Curious to see your top suppliers emissions?
Book a demo for a pilot project
Cancer Research UK, a leading membership organisation based in Great Britain, has been at the forefront of cancer research since its establishment in 2002. With a commitment to saving lives through innovative research and public engagement, the organisation operates extensively across the UK, focusing on various aspects of cancer prevention, diagnosis, and treatment.
As a prominent player in the membership organisation services sector, Cancer Research UK uniquely combines scientific research with community involvement, offering a range of services that include funding groundbreaking studies and providing vital information to the public. The organisation has achieved significant milestones, including the development of life-saving treatments and pioneering research initiatives that have transformed cancer care.
Recognised for its impactful contributions to the field, Cancer Research UK continues to lead the way in cancer research, making strides towards a future where more people survive cancer than ever before.
28
DitchCarbon score
+1 vs industry average
Cancer Research UK’s score of 28 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Cancer Research UK?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medium
Membership Services has typical carbon intensity
Industry performance
0.199
20182025
The Membership Services industry has reduced its overall emissions by 37% since 2018
Reported emissions
No reported emissions data is available for Cancer Research UK yet.
Cancer Research UK's reported carbon emissions
Cancer Research UK, a GB-based "Membership organisation services n.e.c. (91)", has committed to significant climate action. The organisation aims to reduce its Scope 1, 2, and 3 emissions by 50% by 2030, using 2019 levels as a baseline for Scope 1 and 2. They are also working towards achieving net zero emissions by 2050. Cancer Research UK plans to develop a comprehensive Scope 3 baseline during 2022 to enhance its emissions mapping.
While specific Scope 1, 2, and 3 emissions totals for recent years are not disclosed, the organisation provides intensity ratios of tCO2e per full-time equivalent (FTE). In 2024, this ratio was 2,470 tCO2e/FTE. This follows a ratio of 2,030 tCO2e/FTE in 2023, 1,780 tCO2e/FTE in 2021, 1,630 tCO2e/FTE in 2020, and 2,280 tCO2e/FTE in 2019. The organisation states that their Scope 1 and 2 emissions are externally collected and assessed, and they currently disclose some Scope 3 transport emissions.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Cancer Research UK’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Cancer Research UK18 days ago
28
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more